Rampart Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Rampart Investment Management's PFE Position: Q4 2020 in Review
Rampart Investment Management sold out of Pfizer (PFE) in Q4 2020, closing a stake of 36,453 shares — an estimated $1.27M sold.
Rampart Investment Management first reported a position in PFE in Q1 2017 and held it in 15 quarters. The position peaked at $5.65M in Q1 2018. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.
- Rampart Investment Management reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
- Rampart Investment Management sold 36,453 Pfizer shares in Q4 2020, an estimated $1.27M.
- Rampart Investment Management first reported a position in Pfizer in Q1 2017 and held it in 15 quarters.
- Rampart Investment Management's Pfizer position peaked at $5.65M in Q1 2018.
- 2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.
Based on Rampart Investment Management's 13F filing for Q4 2020.